View in EDS

A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia.
Authors: Pratz KW; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA., Kaplan J; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL., Levy M; Baylor University Medical Center, Dallas, TX., Bixby D; University of Michigan Rogel Cancer Center, Ann Arbor, MI., Burke PW; University of Michigan Rogel Cancer Center, Ann Arbor, MI., Erba H; Duke University School of Medicine, Durham, NC., Wise-Draper TM; University of Cincinnati Cancer Center, Cincinnati, OH., Roboz GJ; Weill Cornell Medical College, New York, NY., Papadantonakis N; Winship Cancer Institute of Emory University, Atlanta, GA., Rajkhowa T; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD., Hernandez D; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD., Dobler I; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Gregory RC; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Li C; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Wang S; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Stumpo K; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Kannan K; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Miao H; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Levis M; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD. levisma@jhmi.edu.
Source: Haematologica [Haematologica] 2023 Mar 01; Vol. 108 (3), pp. 705-716. Date of Electronic Publication: 2023 Mar 01.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36226495
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pratz+KW%22">Pratz KW</searchLink>; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Kaplan+J%22">Kaplan J</searchLink>; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Levy+M%22">Levy M</searchLink>; Baylor University Medical Center, Dallas, TX.<br /><searchLink fieldCode="AU" term="%22Bixby+D%22">Bixby D</searchLink>; University of Michigan Rogel Cancer Center, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Burke+PW%22">Burke PW</searchLink>; University of Michigan Rogel Cancer Center, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Erba+H%22">Erba H</searchLink>; Duke University School of Medicine, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Wise-Draper+TM%22">Wise-Draper TM</searchLink>; University of Cincinnati Cancer Center, Cincinnati, OH.<br /><searchLink fieldCode="AU" term="%22Roboz+GJ%22">Roboz GJ</searchLink>; Weill Cornell Medical College, New York, NY.<br /><searchLink fieldCode="AU" term="%22Papadantonakis+N%22">Papadantonakis N</searchLink>; Winship Cancer Institute of Emory University, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Rajkhowa+T%22">Rajkhowa T</searchLink>; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Hernandez+D%22">Hernandez D</searchLink>; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Dobler+I%22">Dobler I</searchLink>; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Gregory+RC%22">Gregory RC</searchLink>; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Li+C%22">Li C</searchLink>; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Wang+S%22">Wang S</searchLink>; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Stumpo+K%22">Stumpo K</searchLink>; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Kannan+K%22">Kannan K</searchLink>; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Miao+H%22">Miao H</searchLink>; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Levis+M%22">Levis M</searchLink>; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD. levisma@jhmi.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220417435%22">Haematologica</searchLink> [Haematologica] 2023 Mar 01; Vol. 108 (3), pp. 705-716. <i>Date of Electronic Publication: </i>2023 Mar 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ferrata+Storti+Foundation%22">Ferrata Storti Foundation </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>0417435 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1592-8721 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203906078%22">03906078 </searchLink><i>NLM ISO Abbreviation: </i>Haematologica <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36226495
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3324/haematol.2022.281216
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 705
    Titles:
      – TitleFull: A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pratz KW
      – PersonEntity:
          Name:
            NameFull: Kaplan J
      – PersonEntity:
          Name:
            NameFull: Levy M
      – PersonEntity:
          Name:
            NameFull: Bixby D
      – PersonEntity:
          Name:
            NameFull: Burke PW
      – PersonEntity:
          Name:
            NameFull: Erba H
      – PersonEntity:
          Name:
            NameFull: Wise-Draper TM
      – PersonEntity:
          Name:
            NameFull: Roboz GJ
      – PersonEntity:
          Name:
            NameFull: Papadantonakis N
      – PersonEntity:
          Name:
            NameFull: Rajkhowa T
      – PersonEntity:
          Name:
            NameFull: Hernandez D
      – PersonEntity:
          Name:
            NameFull: Dobler I
      – PersonEntity:
          Name:
            NameFull: Gregory RC
      – PersonEntity:
          Name:
            NameFull: Li C
      – PersonEntity:
          Name:
            NameFull: Wang S
      – PersonEntity:
          Name:
            NameFull: Stumpo K
      – PersonEntity:
          Name:
            NameFull: Kannan K
      – PersonEntity:
          Name:
            NameFull: Miao H
      – PersonEntity:
          Name:
            NameFull: Levis M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2023 Mar 01
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1592-8721
          Numbering:
            – Type: volume
              Value: 108
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Haematologica
              Type: main
ResultId 1